FLUBLOK QUADRIVALENT NORTHERN HEMISPHERE

This brand name is authorized in Hong Kong, United States

Active ingredients

The drug FLUBLOK QUADRIVALENT NORTHERN HEMISPHERE contains a combination of these active pharmaceutical ingredients (APIs):

1 Influenza, inactivated, surface antigen
UNII 03BDM2QO92 - INFLUENZA A VIRUS A/HAWAII/70/2019 (H1N1) RECOMBINANT HEMAGGLUTININ ANTIGEN
Read about Influenza, inactivated, surface antigen
2 Influenza, inactivated, surface antigen
UNII 8Y5GN9YN6E - INFLUENZA A VIRUS A/MINNESOTA/41/2019 (H3N2) RECOMBINANT HEMAGGLUTININ ANTIGEN
Read about Influenza, inactivated, surface antigen
3 Influenza, inactivated, surface antigen
UNII L7ZT1J7AEZ - INFLUENZA B VIRUS B/WASHINGTON/02/2019 RECOMBINANT HEMAGGLUTININ ANTIGEN
Read about Influenza, inactivated, surface antigen
4 Influenza, inactivated, surface antigen
UNII POQ8DQO9S3 - INFLUENZA B VIRUS B/PHUKET/3073/2013 RECOMBINANT HEMAGGLUTININ ANTIGEN
Read about Influenza, inactivated, surface antigen

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
Country: HK Department of Health Drug Office Identifier(s): 67049, 67050
Country: US FDA, National Drug Code Identifier(s): 49281-720

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.

⇈